A class of medications called cholinesterase inhibitors help to turn back the clock on Alzheimer’s disease’s cognitive symptoms. More than a third people over…
A new study shows that people who have green space, like parks, near their homes are reaping cognitive health benefits. When it comes to…
Depression is the most common mental health disorder in the world, but its signs and symptoms can be elusive. Here’s when to talk to…
Through an examination of school segregation in the Jim Crow South, researchers are probing the link between education and brain health. From the late…
Robert Jacobs, professor of brain and cognitive sciences at the University of Rochester, takes a closer look at why memory slips can actually be…
A new study finds that eating the MIND diet, which consists of foods like vegetables, berries and fish, can reduce the risk of cognitive…
An anti-seizure drug called levetiracetam was found to have extra benefits for people with Alzheimer’s: Not only did it address Alzheimer’s-related seizures; it appeared…
It has long been assumed that a person’s general cognitive ability declines as they grow older. But new research challenges this widely-held assumption, showing that…
Studies have shown: Games can be good for the brain. Jigsaw, crosswords, and number puzzles have been found to improve cognitive function in older…
University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…
Data on Cassava Sciences’ Alzheimer’s drug candidate, simufilam, found it was not only safe, but modified disease biomarkers at six months, and improved cognition…
As part of our BrainTalk series, Being Patient spoke with Sandra Kooij about the symptoms and treatment options of ADHD for older adults and…
Can exergaming — combining exercise and cognitive training in a video game — reduce dementia symptoms in older adults? Interactive gaming consoles like the…
Drugmaker Cassava believes its experimental Alzheimer’s therapy, which sent the company’s stock values surging with a recent phase 2 study announcement, could beat Biogen’s…